BioMedWire Stocks

Timing of Food Intake Impacts Mental Health, Study Says

New research has discovered that the time at which an individual consumes food may impact their mental health. Focusing on what you eat is important for your overall health, but did you know that paying some attention to when you eat may also be good for your mental health? Research has found that abnormal eating times may contribute to poor mental health, including anxiety and depression, as well as weight gain and cardio-metabolic illnesses.

Researchers believe that the circadian clock, which aligns the internal processes in our body at optimal times during the day based on environmental cues such as food and light, may be impacted by an individual’s eating rhythms. They hypothesize that when this primary clock in the brain isn’t in sync with eating rhythm, it affects the ability of the brain to function optimally.

While the brain makes up only 2% of an individual’s body mass, it consumes almost 25% of energy and is especially impacted by changes in a person’s calorie intake, which means that having irregular meal times may have negative health outcomes on an individual.

While the underlying mechanisms remain unknown, researchers believe that there exists an overlap between the neural circuits that govern mood and eating. Digestive hormones also  have an effect on dopamine, which plays a huge role in pleasure, energy and mood.

Researchers also highlight that irregular meal times and modified eating rhythms may contribute to poor mood, noting that irregular meal times may also be a significant cause of mood disorders.

Various studies have found that people with bipolar disorder or depression had abnormal meal times and displayed disturbed internal rhythms, which worsened mood symptoms significantly. Additionally, shift workers have also shown higher rates of anxiety and depression, which researchers hypothesize is due to their irregular eating times.

To help rectify this, individuals can optimize their eating rhythms through intermittent fasting, Evidence proposes that intermittent fasting optimizes the signaling of metabolic hormones, energy metabolism and brain function. Intermittent fasting, which is sometimes referred to as time-restricted eating, has also demonstrated that it can prevent the anxiety and depressive symptoms individuals present with. Additionally, eating at regular times may also decrease the risk of issues such as cardiovascular disease, diabetes and obesity.

Researchers recommend that individuals align their eating rhythms with the sun’s schedule to help keep mental illness at bay and for lasting benefits for their overall well-being. This is, of course, in addition to paying attention to what one eats.

With mental health cases on the rise, one can only hope that companies such as Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) register breakthroughs in their quest to commercialize new lines of treatments for these clinical indications.

NOTE TO INVESTORS: The latest news and updates relating to Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) are available in the company’s newsroom at https://ibn.fm/CYBN

About BioMedWire

BioMedWire (BMW) is a bio-med news and content distribution company that provides (1) access to a network of wire services via InvestorWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with BMW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.

To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information, please visit https://www.biomedwire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer

BioMedWire (BMW)
San Francisco, California
www.biomedwire.com
415.949.5050 Office
Editor@BioMedWire.com

BioMedWire is part of the InvestorBrandNetwork.

Chris@BMW

Share
Published by
Chris@BMW

Recent Posts

UCLA Researchers Develop Method to Fix Fuel Shortages in Cancer Immunotherapy

Many immunotherapies developed to combat cancer fail because the CAR-T cells become exhausted after being…

1 day ago

Medicare Advantage Insurers Record Slowing Growth in Member Enrollment

According to data released by the CMS last week, the expansion of people enrolled in Medicare Advantage…

2 days ago

Earth Science Tech Inc. (ETST) Accelerates Profitability and Governance Transformation, Signals 40% Net Income Growth Trajectory

ETST reported a third fiscal quarter 2026 revenue of $8.4 million, up 14.1% year-over-year Gross…

3 days ago

American Science Suffers as Brain Drain Intensifies

The biomedical ecosystem in the U.S. is facing an unprecedented threat as younger researchers opt to…

4 days ago

LIXTE Biotechnology Holdings Inc. (NASDAQ: LIXT) Expands into Proton Therapy Through Liora Technologies, Advancing the LiGHT System for Next-Generation Cancer Care

LIXTE has acquired Liora Technologies Europe Ltd., securing its proprietary LiGHT system for advanced proton…

5 days ago

Cancer Stress Protein Enables Tumors to Evade the Immune System

A study published this week has found that when cancer cells are stressed, they produce…

1 week ago